Ushering in a new era empowered by biology to create breakthrough products to treat disease in an unprecedented manner by combining mankind’s understanding of genomics, immunology and advanced engineering.


May 20 2016

Abpro Announces Agreements with Two Boston Hospitals

Abpro, an integrated life science company at the forefront of synthetic biology, today announced co-development agreements with Massachusetts General Hospital (MGH) and Brigham and Women’s Hospital (BWH), two of the country’s leading academic medical centers

Read more →

Apr 25 2016

Abpro Announces Investment and Partnership with Essex Bio

Abpro, an integrated life science company at the forefront of synthetic biology, today announced a partnership with Essex Bio, a China-based biopharmaceutical company.

Read more →

Oct 10 2014

Abpro Co-Founder Eugene Chan Wins Nokia Sensing XChallenge

Chan led a team from DNA Medicine Institute (DMI), a Cambridge-based medical technology incubator and lab, that developed rHEALTH, a compact portable device that can run hundreds of clinical lab tests on a single drop of blood with gold standard accuracy.

Read more →

About Us

Abpro is a Massachusetts based biotechnology company. We are pioneers of industrial biochemistry and our mission is to bring innovation to the life sciences industry and ultimately improve living health. Through technology and automation, our DiversImmune™ discovery platform has streamlined all aspects of the process to deliver antibodies at industry leading speeds against previously difficult targets. Our products and discovery services are used by leading academic labs and companies around the world for research purposes, such as diagnostics and therapeutics.

Learn more about abpro →